Skip to main content
. 2016 Jan 18;7:1–4. doi: 10.2147/JBM.S93008

Figure 2.

Figure 2

Changes in PAI-1 levels following aHSCT conditioning regimens with and without significant elevation in HMGB1.

Notes: Group A: HMGB1 levels >1.5-fold higher than baseline. Group B: HMGB1 levels <1.5-fold higher than baseline. *P-values are for comparison with each baseline parameter (before vs day 0, 4, 7, 14, 21, or 28); **Group A vs Group B.

Abbreviations: PAI-1, plasminogen activator inhibitor-1; aHSCT, allogeneic hematopoietic stem cell transplantation; HMGB1, high-mobility group box 1; NS, not significant.